OncoRes Medical’s Post

Surgical Capsule Series 🗣 #100: Timing of Breast Reconstruction As an aspiring surgeon, I'm excited to launch a series of surgical capsules here on LinkedIn, where I'll be discussing and highlighting key topics that are essential to our practice. Breast reconstruction after cancer surgery is a pivotal aspect of patient recovery. When it comes to timing, there are two primary approaches: 🏃♀️ Immediate Reconstruction: Occurs simultaneously with the mastectomy, offering both emotional and cosmetic benefits. ⏳ Delayed Reconstruction: is performed months or even years later, often after additional treatments like radiation. But there’s another approach—do you know what it is? We will cover it in the next capsule 🚨 Educating ourselves and our patients about these options is crucial. For those interested in diving deeper, resources from The Lancet oncology and Annals of Oncology Annals of Oncology provide valuable insights. Let’s continue to empower our patients with the knowledge they need for informed decision-making. 💕 #Surgery_capsules #Breast_surgery #Women_health #Breast_cancer #Breast_reconstruction #Medical_education #Patient_Centered_Care

Determining the order of surgery and chemotherapy is a pivotal step in breast cancer care. Dr. Yara Robertson, a breast surgical oncologist and Medical Advisor for Learn Look Locate, sheds light on how this decision is tailored to individual needs. Her expertise ensures patients receive the best possible care. https://lnkd.in/ez_4VRtM #breastcancersurgery #PatientAdvocacy #breastcancer #breastcancerawareness #breastcancersurvivor

📢 Important Update Advancement in the treatment of low-lying rectal cancer through TaTME (Transanal Total Mesorectal Excision). This cutting-edge surgical technique offers significant benefits for both patients and healthcare professionals. Key Benefits of TaTME: 🔹 **No Permanent Stoma:** Patients can maintain normal bowel function, enhancing their quality of life. 🔹 **Enhanced Precision:** The transanal approach provides better visualization and access, allowing for more precise tumor removal. 🔹 **Oncological Safety:** Comparable, if not superior, oncological results to traditional TME. TaTME represents a promising shift in rectal cancer surgery, offering a viable alternative that combines efficacy with patient-centered benefits. For those specializing in colorectal surgery, integrating TaTME into your practice could significantly enhance patient outcomes. #TaTME #RectalCancer #ColorectalSurgery #MinimallyInvasiveSurgery #SurgicalInnovation 🌟

#WeeklyPodcast Secondary Cytoreductive Surgery in #EndometrialCancer with Drs. Francesco Fanfani and Virginia Vargiu 🎧 https://bit.ly/4130FqI 🔆 Highlights ✔️ Secondary cytoreductive surgery with complete gross resection, has the potential to offer significant survival benefits in recurrent endometrial cancer patients. ✔️Age <65 years, single site recurrence, and nodal or hematogenous recurrence as predictive factors for complete cytoreduction. ✔️The study’s findings could influence the decision making process in treatment selection, offering valuable insights for future prospective studies and potential impacts on research and clinical practice. #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

Laparoscopic surgery is a cutting-edge approach for treating cervical cancer, offering patients a faster recovery and minimal scarring compared to traditional surgery. This technique precisely targets cancerous cells while preserving healthy tissue, reducing post-operative pain and hospitalization duration. Patients benefit from improved quality of life with this advanced method. Staying informed about the latest cancer treatments is crucial for optimal care. Stay updated on advancements in cervical cancer treatment to make well-informed decisions. https://buff.ly/3OYG7bN #CervicalHealth #MinimallyInvasiveSurgery

#PSOGICASE CASE OF THE MONTH #29 with #PaulSugarbaker 'Management of early recurrence in high grade PMP' ❓ How is early recurrence after CRS+HIPEC defined? ❓ What is the right time to intervene? ❓ What is the role of iterative surgery? ❓ Should systemic chemotherapy be administered preoperatively? ❓ What is the role of intraperitoneal treatments? ❓ What systemic chemotherapy regimens are most suited for high grade PMP? 📅 May 2024 ⏰ 11 am EST 8.30 pm 🇮🇳; 5 pm 🇪🇺; 12 pm 🇧🇷; 4 pm 🇬🇧 🇮🇪 Follow #PSOGICASE Live 'X chat' on X/Twitter European Society of Surgical Oncology (ESSO) European School of Peritoneal Surface Oncology (ESPSO) ISSPP e.V. | International Society for the Study of Pleura and Peritoneum Santiago González-Moreno, MD, PhD, FACS, FESSO Lana Bijelic Andreas Brandl Laura Fekete Maximilian Jusufi Carlos Gonzalez de Pedro, Md PhD Miguel E. Alberto V. Vivekanand Sharma Pseudomyxoma Survivor

Join us at the 2024 ASCO Annual Meeting on June 1 from 1:30 - 4:30 PM for a groundbreaking poster session on "Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis." This study utilizing real-world data from the CancerLinQ Discovery database has developed a machine learning model to predict 1-year survival for patients undergoing surgery for pancreatic ductal adenocarcinoma (PDAC). This innovative approach offers a more accurate way to stratify patient risk and make informed treatment decisions. Findings show that factors like chemotherapy, tumor size, age, and lab data contribute to predicting outcomes. Read more: https://hubs.ly/Q02yCQ6S0 #CancerResearch #MachineLearning #PatientOutcomes #PancreaticCancer #MedicalAdvancements

Participants’ perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study Participants’ Perspectives on Weight Loss Intervention Trial Before Colorectal Cancer Surgery Key Findings Patients with excess weight awaiting colorectal cancer surgery were motivated by the offer of structured weight loss support that could potentially improve their surgical outcomes. However, concerns about the potential unpalatability of the intervention diet and side effects were also expressed. Positive attitudes of clinicians towards the trial facilitated recruitment, but participants were disappointed when they were randomized to usual care due to clinical teams’ overemphasis on the benefits of losing weight. Practical Solutions and Value The study highlights the importance of balanced communication of equipoise to minimize disappointment from randomization to usual care and differential dropout from the trial. This emphasizes the need for clear and comprehensive information for patients to make informed decisions about trial participation. Clinical Trial Registration ISRCTN39207707, Registration date 13/03/2023 https://lnkd.in/ga4rUnKu #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

Register now for a forthcoming VCCC Alliance event focused on sarcoma. Attendees will explore the complexities of sarcoma diagnoses and advanced treatment options. Targeted at both paediatric and adult trainees, utilising case study discussions and Q&A, participants will gain in-depth knowledge of the challenges and future directions of sarcoma treatment. The session will foster a comprehensive understanding of the complex landscape of sarcoma management. Medical trainees will gain a deeper understanding of: - Foundational principles of sarcoma diagnoses - The role of pathology in sarcoma diagnosis and management - Chemotherapy options and considerations for sarcoma patients - The role of radiotherapy and surgery in sarcoma treatment - Sarcoma diagnoses specific to the AYA population and their management - Precision, immune-oncology and adult sarcoma Find out more and register https://buff.ly/3VGpFBr #sarcoma

"Revolutionizing Prostate Cancer Treatment: The Paradigm Shift Towards Minimally Invasive Surgery Minimally invasive surgery has emerged as a revolutionary approach in the landscape of prostate cancer treatment, fundamentally altering the traditional treatment algorithm. Through techniques like robotic-assisted laparoscopic prostatectomy, surgeons can now precisely target cancerous tissue while preserving surrounding healthy areas, leading to improved oncological outcomes and reduced risks of complications. This precision is paramount in ensuring better long-term prognosis for patients. Additionally, the minimally invasive nature of these procedures translates to faster recovery times, minimized blood loss, reduced post-operative pain, and shorter hospital stays. Such benefits not only enhance patients' quality of life but also contribute to a more efficient healthcare system. Moreover, the cosmetic advantages of minimally invasive surgery cannot be overlooked. Smaller scars and less visible surgical marks not only improve aesthetic outcomes but also boost patient satisfaction. Furthermore, these advanced techniques offer a broader range of surgical options, including nerve-sparing procedures aimed at preserving erectile function and urinary continence, thus addressing important aspects of patients' post-operative life. #PrecisionSurgery #FasterRecovery #CosmeticAdvantages #EnhancedOptions #PatientEmpowerment #OptimizedOutcomes"